Prevention of future incidents and investigational lines

Reports of Practical Oncology and Radiotherapy

Volumn 16, Issue 4, 2011, Pages 153-161

  Martín, Miguel J ^a   Zapatero, José ^a   López, Mario ^b  

^a HOSPITAL CENTRAL DE LA DEFENSA GÓMEZ ULLA   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Biodosimeter; Nuclear prevention; Radioactive accident; Radiological incident; Radioprotection

Indexed keywords

AMIFOSTINE; CAPTOPRIL; COPPER ZINC SUPEROXIDE DISMUTASE; CORTICOSTEROID; DEXAMETHASONE; LOSARTAN; MELATONIN; PALIFERMIN; PENTOXIFYLLINE; PREDNISONE; RADIOACTIVE MATERIAL; RADIOPROTECTIVE AGENT; SALAZOSULFAPYRIDINE; TOCOPHEROL;

ACUTE RADIATION SYNDROME; BLOOD ANALYSIS; DICENTRIC CHROMOSOME; DOSIMETRY; ELECTRON SPIN RESONANCE; ENTEROPATHY; FIBROSIS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOASSAY; IN VIVO STUDY; KIDNEY DISEASE; LIVER INJURY; LUNG INJURY; METABOLOMICS; MICROARRAY ANALYSIS; MUCOSA INFLAMMATION; PROCTITIS; RADIATION; RADIATION EXPOSURE; RADIATION HAZARD; RADIATION INDUCED EMESIS; RADIATION INJURY; RADIATION PNEUMONIA; RADIATION PROTECTION; RADIATION RESPONSE; REVIEW; TERRORISM; XEROSTOMIA;

EID: 79960652031     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rpor.2011.06.004     Document Type: Review

References (50)

1. Bland S.A. Chemical biological and radiation casualties: critical care considerations. JR Army Med Corps 2009, 155(2):160-171.
2. Zielinski J.M., Garner M.J., Band P.R., et al. Health outcomes of low-dose ionizing radiation exposure among medical workers: a cohort study of the Canadian national dose registry of radiation workers. Int J Occup Med Environ Health 2009, 22(2):149-156.
3. Poston J.W., Ford J.R. How do we combine science and regulations for decision making following a terrorist incident involving radioactive materials?. Health Phys 2009, 97(5):537-541.
4. Butler G.C., Nicholas J., Lackland D.T., et al. Perspectives of those impacted: airline pilot's perspective. Health Phys 2000, 79(5):602-607.
5. Akashi M., Kumagaya K., Kondo H., et al. Concerns of disaster medical assistance team (DMAT) members about troubles at the nuclear power plant: experience from the Niigata Chuetsu-Oki earthquake. Jpn Health Phys 2010, 98(July (6)):804-809.
6. Wolbarst A.B., Wiley A.L., Nemhauser J.B., et al. Medical response to a major radiologic emergency: a primer for medical and public health practitioners. Radiology 2010, 254(3):660-677.
7. Little M.P. Heterogeneity of variation of relative risk by age at exposure in the Japanese atomic bomb survivors. Radiat Environ Biophys 2009, 48(3):253-262.
8. Atkinson A.L., Rosenthal A. Thyroid carcinoma secondary to radiation cloud exposure from the chernobyl incident of 1986: a case study. Case Rep Oncol 2010, 3(1):83-87.
9. Romm H., Wilkins R.C., Coleman C.N., et al. Biological dosimetry by the triage dicentric chromosome assay: potential implications for treatment of acute radiation syndrome in radiological mass casualties. Radiat Res 2011, 175(March (3)):397-404.
10. Huber R., Braselmann H., Geinitz H. Chromosomal radiosensitivity and acute radiation side effects after radiotherapy in tumour patients - a follow-up study. Radiat Oncol 2011, 6:32.
11. Gougelet R.M., Rea M.E., Nicolalde R.J. The view from the trenches: part 1 - emergency medical response plans and the need for EPR screening. Health Phys 2010, 98(February (2)):118-127.
12. Williams B.B., Dong R., Kmiec M., et al. Development of in vivo tooth EPR for individual radiation dose estimation and screening. Health Phys 2010, 98(February (2)):327.
13. Simon S.L., Bouville A., Kleinerman R. Current use and future needs of biodosimetry in studies of long-term health risk following radiation exposure. Health Phys 2010, 98(February (2)):109-117.
14. Okunieff P., Chen Y., Maguire D.J. Molecular markers of radiation-related normal tissue toxicity. Cancer Metastasis Rev 2008, 27(September (3)):363-374.
15. Partridge M.A., Chai Y., Zhou H., et al. High-throughput antibody-based assays to identify and quantify radiation-responsive protein biomarkers. Int J Radiat Biol 2010, 86(4):321-328.
16. Salerno A., Zhang J., Bhatla A., et al. Design considerations for a minimally invasive high-throughput automation system for radiation biodosimetry. IEEE Int Conf Autom Sci Eng, 2007 CASE 2007, 846-852.
17. Garty G., Chen Y., Salerno A., et al. The rabit: a rapid automated biodosimetry tool for radiological triage. Health Phys 2010, 98(February (2)):209-217.
18. Brengues M., Paap B., Bittner M., et al. Biodosimetry on small blood volume using gene expression assay. Health Phys 2010, 98(2):179-185.
19. Paul S., Barrer C.A., Turner H.C., et al. Prediction of in vivo radiation dose status in radiotherapy patients using ex vivo and in vivo gene expression signatures. Radiat Res 2011, 175(March (3)):257-265.
20. Patterson A.D., Lanz C., Gonzalez F.J., et al. The role of mass spectrometry-based metabolomics in medical countermeasures against radiation. Mass Spectrom Rev 2010, 29(May-June (3)):503-521.
21. Radiation Research Society Meeting report radiation exposures in medicine: biological and public health significance American statistical association conference on radiation and health Annapolis, Maryland. Radiat Res 2011, 175(June):131-142.
22. Brush J., Lipnick S.L., Phillips T., et al. Molecular mechanisms of late normal tissue injury. Semin Radiat Oncol 2007, 17:121-130.
23. Zhao W., Diz I., Robbins M.E. Oxidative damage pathways in relation to normal tissue injury. Br J Radiol 2007, 80:S23-S31.
24. Moulder J.E., Cohen E.P. Future strategies for mitigation and treatment of chronic radiation-induced normal tissue injury. Semin Radiat Oncol 2007, 17:141-148.
25. Wasserman T.H., Brizel D.M., Henke M., et al. Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head and neck cancer: 2-year follow-up of a prospective, randomized, phase III trial. Int J Radiat Oncol Biol Phys 2005, 63(4):985-990.
26. Rubin J.S., Bottaro D.B., Chedid M., et al. Keratinocyte growth factor. Cell Biol Int 1995, 19:399-411.
27. Spielberger R., Stiff P., Bensinger W., et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 2004, 351(25):2590-2598.
28. Henke M., Alfonsi P., Foa, et al. Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer. J Clin Oncol 2011, 13(June). (Epub ahead of print).
29. Vijayalaxmi, Reiter R.J., Tan D.X., Herman T.S., Thomas C.R. Melatonin as a radioprotective agent: A review. Int J Radiat Oncol Biol Phys 2004, 59:639-653.
30. Korkmaz A., Tan D.X., Riter R.J. Melatonine: an established radioprotective agent against Japan nuclear disaster. TAF Prev Med Bull 2011, 10.(2).
31. Ghosh S.N., Zhang R., Fish B.L., et al. Renin-angiotensin system suppression mitigates experimental radiation pneumonitis. Int J Radiat Oncol Biol Phys 2009, 75(December (5)):1528-1536.
32. Cohen E.P., Robbins M.E.C. Radiation nephropathy. Semin Nephrol 2003, 23:486-499.
33. Kim J.H., Brown S.L., Kolozsvary A. Modification of radiation injury by ramipril, inhibitor of angiotensin converting enzyme, on optic neuropathy in the rat. Radiat Res 2004, 161:137-142.
34. Boerma M., Hauer-Jensen M. Preclinical research into basic mechanisms of radiation-induced heart disease. Cardiol Res Pract 2011, Article ID 858262, 8 pages.
35. Michelson A. Medical aspects of superoxide dismutase. Life chemistry reports 1987, Harwood Academic Publishers, United Kingdom, p. 1-142.
36. Carpenter M., Epperly M.W., Agarwal A. Inhalation delivery of manganese superoxide dismutase-plasmid/liposomes protects the murine lung from irradiation damage. Gene Ther 2005, 12:685-693.
37. Greenberger J.S., Epperly M.W., Gretton J. Radioprotective gene therapy. Curr Gene Ther 2003, 3:183-195.
38. Delanian S., Lefaix J.L. Current management for late normal tissue injury: radiation-induced fibrosis and necrosis. Semin Radiat Oncol 2007, 17:99-107.
39. López M., Cerezo L. Toxicity associated to radiotherapy treatment in lung cancer patients. Clin Translat Oncol 2007, 9:506-512.
40. López M., Martín M., Cerezo L., et al. Gastrointestinal toxicity associated to radiation therapy. Clin Translat Oncol 2010, 12:554-561.
41. Laurent C., Pouget J.-P., Voisin P. Modulation of DNA damage by pentoxifylline and alpha-tocopherol in skin fibroblasts exposed to gammarays. Radiat Res 2005, 164:63-72.
42. Laurent C., Voisin P., Pouget J.P. DNA damage in cultured skin microvascular endothelial cells exposed to gamma rays and treated by the combination pentoxifylline and alpha-tocopherol. Int J Radiat Biol 2006, 82:309-321.
43. Singh V.K., Brown D.S., Kao T.C., Seed T.M. Preclinical development of a bridging therapy for radiation casualties. Exp Hematol 2010, 38(1):61-70.
44. Joshi R., Kumar S., Unnikrishnan M., et al. Free radical scavenging reactions of sulfasalazine, 5-aminosalicylic acid and sulfapyridine: mechanistic aspects and antioxidant activity. Free Radic Res 2005, 39(November 11):1163-1172.
45. Hotz M.E., Fliedner T.M., Meineke V. Radiation accident preparedness: a European approach to train physicians to manage mass radiation casualties. Health Phys 2010, 98:894-897.
46. Travis E. Genetic susceptibility to late normal tissue injury. Semin Radiat Oncol 2007, 17:149-155.
47. Epperly M.W., Smith T., Zhang X., et al. Modulation of in utero total body irradiation induced newborn mouse growth retardation by maternal manganese superoxide dismutase-plasmid liposome (MnSOD-PL) gene therapy. Gene Ther 2011, 18(June 6):579-583.
48. Maier P., Veldwijk M.R., Wenz F. Radioprotective gene therapy. Expert Opinion on Biological Therapy 2011, Posted online May 2.
49. Chun-Jie L.I.U., Xiao-Qin H.A., Jun-Jun JIAN.G. Keratinocyte growth factor (KGF) gene therapy mediated by an attenuated form of Salmonella typhimurium ameliorates radiation induced pulmonary injury in rats. J Radiat Res 2011, 52:176-184.
50. Przybyszewska M. Soluble TNF-α receptor I encoded on plasmid vector and its application in experimental gene therapy of radiation-induced lung fibrosis. Arch Immunol Ther Exp (Warsz) 2011, 59(August 4):315-326.